Endogenous Cell Repair of Chronic Demyelination
Open Access
- 1 March 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 65 (3) , 245-256
Abstract
In multiple sclerosis lesions, remyelination typically fails with repeated or chronic demyelinating episodes and results in neurologic disability. AcuKeywords
This publication has 51 references indexed in Scilit:
- The ErbB4 Neuregulin Receptor Mediates Suppression of Oligodendrocyte MaturationThe Journal of Neuroscience, 2005
- Targeted disruption of the FGF-2 gene affects the response to peripheral nerve injuryMolecular and Cellular Neuroscience, 2004
- Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosisNature, 2003
- PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelinationJournal of Neurobiology, 2003
- Growth factor treatment promotes mobilization of young but not aged adult subventricular zone precursors in response to demyelinationJournal of Neuroscience Research, 2002
- Fibroblast Growth Factor-2 (FGF-2) and Platelet-Derived Growth Factor AB (PDGFAB) Promote Adult SVZ-Derived Oligodendrogenesis in VivoMolecular and Cellular Neuroscience, 2002
- Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 miceGene Therapy, 2001
- Genetic Approaches to Neurotrauma Research: Opportunities and Potential Pitfalls of Murine ModelsExperimental Neurology, 1999
- Developmental and FGF-2-Mediated Regulation of Syndecans (1–4) and Glypican in OligodendrocytesMolecular and Cellular Neuroscience, 1996
- A novel myelin-associated glycoprotein defined by a mouse monoclonal antibodyJournal of Neuroimmunology, 1984